Ensign Peak Advisors, Inc Charles River Laboratories International, Inc. Transaction History
Ensign Peak Advisors, Inc
- $56.1 Billion
- Q3 2024
A detailed history of Ensign Peak Advisors, Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 16,122 shares of CRL stock, worth $3.21 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,122
Previous 15,722
2.54%
Holding current value
$3.21 Million
Previous $3.25 Million
2.22%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding CRL
# of Institutions
696Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.22 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.01 Billion0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$746 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$425 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$387 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.1B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...